415: ERG Unlocked: Targeting the PNT Domain with PBITE-1

PNAS - This episode breaks down a PNAS study that identifies a druggable pocket in the ERG transcription factor PNT domain and describes PBITE-1, a small-molecule probe that binds this pocket to inhibit ERG-driven prostate cancer models. Key terms: ERG, PNT domain, PBITE-1, prostate cancer, small-molecule inhibitor.

Study Highlights:
The authors show that TMPRSS2:ERG-positive prostate cancer cells remain dependent on ERG for survival and tumor maintenance. A domain-focused DSF screen identified F0341 as a PNT-domain binder and SAR optimization yielded PBITE-1, which engages a solvent-exposed pocket spanning two helices and a flexible loop. PBITE-1 selectively stabilizes ERG in cells, suppresses ERG target genes, reduces proliferation and invasion, induces apoptosis in ERG-positive cell lines and organoids, and triggers tumor cell apoptosis in VCaP xenografts.

Conclusion:
The ERG N-terminal PNT domain contains a structurally coherent, ligandable pocket; PBITE-1 provides proof-of-concept that ERG can be directly targeted by small molecules, laying groundwork for future ERG-directed inhibitors and degrader strategies for TMPRSS2:ERG-driven cancers.

Music:
Enjoy the music based on this article at the end of the episode.

Article title:
A ligandable PNT domain establishes ERG as a directly targetable oncogenic driver in prostate cancer

Journal:
PNAS

DOI:
10.1073/pnas.2537437123

Reference:
https://doi.org/10.1073/pnas.2537437123

License:
This episode is based on an open-access article published under the Creative Commons Attribution 4.0 International License (CC BY 4.0) – https://creativecommons.org/licenses/by/4.0/

Support:
Base by Base is independent and ad-free — no sponsors, no paywall. If an episode was worth your time, chip in and keep the papers audited and the original songs coming:
❤️ Support monthly: https://buy.stripe.com/cNifZhclVebvagk2JDgEg01
☕ One-time donation: https://donate.stripe.com/7sY4gz71B2sN3RWac5gEg00
More at basebybase.com

On PaperCast Base by Base you'll discover the latest in genomics, functional genomics, structural genomics, and proteomics.

Episode link: https://basebybase.com/episodes/erg-pnt-pbite-1

QC:
This episode was checked against the original article PDF and publication metadata for the episode release published on 2026-07-18.

QC Scope:
- article metadata and core scientific claims from the narration
- excludes analogies, intro/outro, and music
- transcript coverage: Audited the transcript sections describing ERG dependency in TMPRSS2:ERG-positive prostate cancer, DSF screening and hit identification (F0341), SAR optimization to PBITE-1, binding and target engagement assays (NMR, BLI, CETSA), cellular effects (viability, apoptosis, ERG target gene suppression), organoid and in vivo
- transcript topics: ERG dependency in TMPRSS2:ERG-positive prostate cancer; Domain-focused differential scanning fluorimetry (DSF) screen; PBITE-1 discovery and SAR optimization; PBITE-1 binding interface mapping to ERG PNT domain (NMR, docking, H2/H6); Target engagement and cellular effects (CETSA, cell viability, apoptosis, ERG target genes); Organoid and in vivo VCaP xenograft data

QC Summary:
- factual score: 10/10
- metadata score: 10/10
- supported core claims: 7
- claims flagged for review: 0
- metadata checks passed: 4
- metadata issues found: 0

Metadata Audited:
- article_doi
- article_title
- article_journal
- license

Factual Items Audited:
- TMPRSS2:ERG fusion occurs in approximately 50% of prostate cancers in patients of European ancestry.
- PBITE-1 engages a discrete solvent-exposed surface within the ERG PNT domain, defining a ligand-binding pocket.
- PBITE-1 directly binds the ERG PNT domain and stabilizes full-length ERG in cell...